z-logo
Premium
Role of oral pentosan polysulphate in the reduction of local side effects of BCG therapy in patients with non‐muscle‐invasive bladder cancer: a pilot study
Author(s) -
Yadav Suresh,
Tomar Vinay,
Yadav Sher Singh,
Priyadarshi Shivam,
Banerjee Indraneel
Publication year - 2016
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/bju.13489
Subject(s) - dysuria , medicine , group b , bladder cancer , visual analogue scale , placebo , overactive bladder , urology , urinary system , cancer , gastroenterology , anesthesia , alternative medicine , pathology
Objective To assess the role of oral pentosan polysulphate ( PPS ) in the reduction of bacille Calmette‐Guérin ( BCG )‐related local side effects in patients with high grade Ta/T1 non‐muscle‐invasive bladder cancer ( NMIBC ). Patients and Methods A total of 32 symptomatic patients receiving BCG instillation were randomized into three groups: group A received placebo (vitamin B complex tablet) thrice daily; group B received PPS 100 mg thrice daily; and group C received PPS 100 mg once daily and placebo (vitamin B complex tablet) twice daily for 6 weeks. A visual analogue scale ( VAS ) score for bladder pain, Overactive Bladder‐Validated 8 Question Screener ( OAB ‐V8) scores and dysuria were evaluated in the three groups before and during each weekly visit for BCG instillation. Results The mean ± sd post‐treatment VAS scores were significantly lower in groups B (4.4 ± 1.2) and C (5.8 ± 0.8) than in group A (8 ± 0.4). In addition, the post‐treatment VAS score was significantly lower in group B than in group C ( P <0.01). The mean post‐treatment OAB ‐V8 score was significantly lower only in group B (decreased from 15.5 to 9.7). Dysuria decreased in groups B and C but persisted in group A. Conclusion The present study shows that oral PPS (100 mg) thrice daily is effective in relieving BCG ‐related local side effects.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here